In this discussion, Patrick Pestalozzi, CEO of Abionic and a seasoned leader in the medtech industry, shares insights into revolutionary sepsis detection technology. He explains how their product, abioSCOPE®, can identify sepsis up to 72 hours before symptoms appear, emphasizing its potential for improving emergency care. The conversation also delves into the challenges of innovating in health tech, navigating leadership transitions, and strategies to secure funding and succeed in international markets. François Capel contributes his expertise on fostering innovation in high-stakes environments.
